A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Ianalumab
Related studies linked through entity extraction aliases.
Managed Access Programs for VAY736, Ianalumab
- Status
- AVAILABLE
- Phase
- N/A
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
- Status
- RECRUITING
- Phase
- PHASE2
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
- Status
- RECRUITING
- Phase
- PHASE2
Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1